Skip to main content
Erschienen in: European Journal of Trauma and Emergency Surgery 3/2019

26.04.2018 | Original Article

Platelet-rich plasma as an additional therapeutic option for infected wounds with multi-drug resistant bacteria: in vitro antibacterial activity study

verfasst von: Rıza Aytaç Çetinkaya, Ercan Yenilmez, Patrizio Petrone, Soner Yılmaz, Bayhan Bektöre, Berksan Şimsek, Tuğba Kula Atik, Mustafa Özyurt, Aytekin Ünlü

Erschienen in: European Journal of Trauma and Emergency Surgery | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Infected wounds, such as diabetic foot infections, are mostly polymicrobial and microorganisms have high resistance rates to antimicrobials. Infected wounds in diabetic patients have high cost, morbidity, and mortality rates. Based on these facts, there is a need for supportive localized treatment options such as platelet-rich plasma (PRP) implementations. Demonstrating the in vitro antimicrobial effect, our aim was to lead up to clinical trials of localized PRP implementations in infected wounds such as diabetic foot infections. In this study, we aimed to demonstrate the in vitro antibacterial activity of PRP against methicilin-resistant Staphylococcus aureus (MRSA) and three more multi-drug resistant bacteria species that are important and hard-to-treat in wound infections.

Materials and methods

In vitro antimicrobial activity of autologous PRP, platelet-poor plasma (PPP), and phosphate-buffered saline (PBS) on methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus spp., extended spectrum beta lactamase producing Klebsiella pneumoniae, and carbapenem-resistant Pseudomonas aeruginosa was compared by assessment of bacterial growth on agar plates and antimicrobial susceptibility test results.

Results

When compared to control group, PRP and PPP significantly suppressed bacterial growth of MRSA, K. pneumoniae, and P. aeruginosa at 1st, 2nd, 5th, and 10th hours of incubation (p < 0.05). VRE was the only bacteria that PRP and PPP showed limited activity against. When compared to PPP, PRP showed higher activity against MRSA, K. pneumoniae, and P. aeruginosa. However, the differences between PRP and PPP were statistically significant only against MRSA and P. aeruginosa at the first hour of incubation.

Conclusions

Emerging PRP and other platelet-derived products seem to be promising alternative tools besides antibiotic treatment, debridement, negative pressure wound therapy, hyperbaric oxygen therapy, and other treatment options for treating diabetic foot infections.
Literatur
1.
Zurück zum Zitat Friedman ND, Temkin E, Carmeli Y. The negative impact of antibiotic resistance. Clin Microbiol Infect. 2016;22(5):416–22. CrossRefPubMed Friedman ND, Temkin E, Carmeli Y. The negative impact of antibiotic resistance. Clin Microbiol Infect. 2016;22(5):416–22. CrossRefPubMed
2.
Zurück zum Zitat Huysman E, Mathieu C. Diabetes and peripheral vascular disease. Acta Chir Belg. 2009;109(5):587–94. CrossRefPubMed Huysman E, Mathieu C. Diabetes and peripheral vascular disease. Acta Chir Belg. 2009;109(5):587–94. CrossRefPubMed
3.
Zurück zum Zitat Lipsky BA. International consensus group on diagnosing, treating the infected diabetic foot. A report from the international consensus on diagnosing and treating the infected diabetic foot. Diabetes Metab Res Rev. 2004;20(Suppl 1):S68-77. PubMed Lipsky BA. International consensus group on diagnosing, treating the infected diabetic foot. A report from the international consensus on diagnosing and treating the infected diabetic foot. Diabetes Metab Res Rev. 2004;20(Suppl 1):S68-77. PubMed
4.
Zurück zum Zitat Yeaman MR. Platelets in defense against bacterial pathogens. Cell Mol Life Sci. 2010;67(4):525–44. CrossRefPubMed Yeaman MR. Platelets in defense against bacterial pathogens. Cell Mol Life Sci. 2010;67(4):525–44. CrossRefPubMed
5.
Zurück zum Zitat Piccin A, Di Pierro AM, Canzian L, Primerano M, Corvetta D, Negri G, et al. Platelet gel: a new therapeutic tool with great potential. Blood Transfus. 2017;15(4):333–40. PubMedPubMedCentral Piccin A, Di Pierro AM, Canzian L, Primerano M, Corvetta D, Negri G, et al. Platelet gel: a new therapeutic tool with great potential. Blood Transfus. 2017;15(4):333–40. PubMedPubMedCentral
6.
Zurück zum Zitat Cetinkaya RA, Yilmaz S, Unlu A, Petrone P, Marini C, Karabulut E, et al. The efficacy of platelet-rich plasma gel in MRSA-related surgical wound infection treatment: an experimental study in an animal model. Eur J Trauma Emerg Surg. 2017. Cetinkaya RA, Yilmaz S, Unlu A, Petrone P, Marini C, Karabulut E, et al. The efficacy of platelet-rich plasma gel in MRSA-related surgical wound infection treatment: an experimental study in an animal model. Eur J Trauma Emerg Surg. 2017.
7.
Zurück zum Zitat Yang LC, Hu SW, Yan M, Yang JJ, Tsou SH, Lin YY. Antimicrobial activity of platelet-rich plasma and other plasma preparations against periodontal pathogens. J Periodontol. 2015;86(2):310–8. CrossRefPubMed Yang LC, Hu SW, Yan M, Yang JJ, Tsou SH, Lin YY. Antimicrobial activity of platelet-rich plasma and other plasma preparations against periodontal pathogens. J Periodontol. 2015;86(2):310–8. CrossRefPubMed
8.
Zurück zum Zitat Grigoropoulou P, Eleftheriadou I, Jude EB, Tentolouris N. Diabetic foot infections: an update in diagnosis and management. Curr Diab Rep. 2017;17(1):3. CrossRefPubMed Grigoropoulou P, Eleftheriadou I, Jude EB, Tentolouris N. Diabetic foot infections: an update in diagnosis and management. Curr Diab Rep. 2017;17(1):3. CrossRefPubMed
9.
Zurück zum Zitat Kosinski MA, Lipsky BA. Current medical management of diabetic foot infections. Expert Rev Anti Infect Ther. 2010;8(11):1293–305. CrossRefPubMed Kosinski MA, Lipsky BA. Current medical management of diabetic foot infections. Expert Rev Anti Infect Ther. 2010;8(11):1293–305. CrossRefPubMed
10.
Zurück zum Zitat Yeaman MR. Platelets: at the nexus of antimicrobial defence. Nat Rev Microbiol. 2014;12(6):426–37. CrossRefPubMed Yeaman MR. Platelets: at the nexus of antimicrobial defence. Nat Rev Microbiol. 2014;12(6):426–37. CrossRefPubMed
11.
Zurück zum Zitat Steed DL. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group. J Vasc Surg. 1995;21(1):71–8; discussion 9–81. CrossRefPubMed Steed DL. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group. J Vasc Surg. 1995;21(1):71–8; discussion 9–81. CrossRefPubMed
12.
Zurück zum Zitat Wieman TJ, Smiell JM, Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study. Diabetes Care. 1998;21(5):822–7. CrossRefPubMed Wieman TJ, Smiell JM, Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study. Diabetes Care. 1998;21(5):822–7. CrossRefPubMed
13.
Zurück zum Zitat Hemecour P. Sodium carboxymethylcellulose aqueous-based gel vs. becaplermin gel in patients with nonhealing lower extremity diabetic ulcers. Wounds. 1998;10:69–75. Hemecour P. Sodium carboxymethylcellulose aqueous-based gel vs. becaplermin gel in patients with nonhealing lower extremity diabetic ulcers. Wounds. 1998;10:69–75.
14.
Zurück zum Zitat Smiell JM, Wieman TJ, Steed DL, Perry BH, Sampson AR, Schwab BH. Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies. Wound Repair Regen. 1999;7(5):335–46. CrossRefPubMed Smiell JM, Wieman TJ, Steed DL, Perry BH, Sampson AR, Schwab BH. Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies. Wound Repair Regen. 1999;7(5):335–46. CrossRefPubMed
15.
Zurück zum Zitat Robson M. Integrating the results of phase IV (postmarketing) clinical trial with four previous trials reinforces the position that Regranex (becaplermin) gel 0.01% is an effective adjunct to the treatment of diabetic foot ulcers. J Appl Res. 2005(5):35–45. Robson M. Integrating the results of phase IV (postmarketing) clinical trial with four previous trials reinforces the position that Regranex (becaplermin) gel 0.01% is an effective adjunct to the treatment of diabetic foot ulcers. J Appl Res. 2005(5):35–45.
16.
Zurück zum Zitat Amable PR, Carias RB, Teixeira MV, da Cruz Pacheco I, Correa do Amaral RJ, Granjeiro JM, et al. Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors. Stem Cell Res Ther. 2013;4(3):67. CrossRefPubMedPubMedCentral Amable PR, Carias RB, Teixeira MV, da Cruz Pacheco I, Correa do Amaral RJ, Granjeiro JM, et al. Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors. Stem Cell Res Ther. 2013;4(3):67. CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Jago R, Jacox RF. Cellular source and charcter of a heatstable bactericidal property associated with rabbit and rat platelets. J Exp Med. 1961;113:701–11. CrossRefPubMedPubMedCentral Jago R, Jacox RF. Cellular source and charcter of a heatstable bactericidal property associated with rabbit and rat platelets. J Exp Med. 1961;113:701–11. CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Kahn RA, Flinton LJ. The relationship between platelets and bacteria. Blood. 1974;44(5):715–21. PubMed Kahn RA, Flinton LJ. The relationship between platelets and bacteria. Blood. 1974;44(5):715–21. PubMed
20.
Zurück zum Zitat Czuprynski CJ, Balish E. Interaction of rat platelets with Listeria monocytogenes. Infect Immun. 1981;33(1):103–8. PubMedPubMedCentral Czuprynski CJ, Balish E. Interaction of rat platelets with Listeria monocytogenes. Infect Immun. 1981;33(1):103–8. PubMedPubMedCentral
21.
Zurück zum Zitat Miragliotta G, Lafata M, Jirillo E. Anti-bacterial activity mediated by human platelets. Agents Actions. 1988;25(3–4):401–6. CrossRefPubMed Miragliotta G, Lafata M, Jirillo E. Anti-bacterial activity mediated by human platelets. Agents Actions. 1988;25(3–4):401–6. CrossRefPubMed
22.
Zurück zum Zitat Li H, Li B. PRP as a new approach to prevent infection: preparation and in vitro antimicrobial properties of PRP. J Vis Exp. 2013(74):e50351. Li H, Li B. PRP as a new approach to prevent infection: preparation and in vitro antimicrobial properties of PRP. J Vis Exp. 2013(74):e50351.
23.
Zurück zum Zitat Li H, Hamza T, Tidwell JE, Clovis N, Li B. Unique antimicrobial effects of platelet-rich plasma and its efficacy as a prophylaxis to prevent implant-associated spinal infection. Adv Healthc Mater. 2013;2(9):1277–84. CrossRefPubMedPubMedCentral Li H, Hamza T, Tidwell JE, Clovis N, Li B. Unique antimicrobial effects of platelet-rich plasma and its efficacy as a prophylaxis to prevent implant-associated spinal infection. Adv Healthc Mater. 2013;2(9):1277–84. CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Mariani E, Filardo G, Canella V, Berlingeri A, Bielli A, Cattini L, et al. Platelet-rich plasma affects bacterial growth in vitro. Cytotherapy. 2014;16(9):1294–304. CrossRefPubMed Mariani E, Filardo G, Canella V, Berlingeri A, Bielli A, Cattini L, et al. Platelet-rich plasma affects bacterial growth in vitro. Cytotherapy. 2014;16(9):1294–304. CrossRefPubMed
25.
Zurück zum Zitat Fitzpatrick J, Bulsara MK, McCrory PR, Richardson MD, Zheng MH. Analysis of platelet-rich plasma extraction: variations in platelet and blood components between 4 common commercial kits. Orthop J Sports Med. 2017;5(1):2325967116675272. CrossRefPubMedPubMedCentral Fitzpatrick J, Bulsara MK, McCrory PR, Richardson MD, Zheng MH. Analysis of platelet-rich plasma extraction: variations in platelet and blood components between 4 common commercial kits. Orthop J Sports Med. 2017;5(1):2325967116675272. CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Dhurat R, Sukesh M. Principles and methods of preparation of platelet-rich plasma: a review and author’s perspective. J Cutan Aesthet Surg. 2014;7(4):189–97. CrossRefPubMedPubMedCentral Dhurat R, Sukesh M. Principles and methods of preparation of platelet-rich plasma: a review and author’s perspective. J Cutan Aesthet Surg. 2014;7(4):189–97. CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Drago L, Bortolin M, Vassena C, Taschieri S, Del Fabbro M. Antimicrobial activity of pure platelet-rich plasma against microorganisms isolated from oral cavity. BMC Microbiol. 2013;13:47. CrossRefPubMedPubMedCentral Drago L, Bortolin M, Vassena C, Taschieri S, Del Fabbro M. Antimicrobial activity of pure platelet-rich plasma against microorganisms isolated from oral cavity. BMC Microbiol. 2013;13:47. CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Anitua E, Alonso R, Girbau C, Aguirre JJ, Muruzabal F, Orive G. Antibacterial effect of plasma rich in growth factors (PRGF(R)-Endoret(R)) against Staphylococcus aureus and Staphylococcus epidermidis strains. Clin Exp Dermatol. 2012;37(6):652–7. CrossRefPubMed Anitua E, Alonso R, Girbau C, Aguirre JJ, Muruzabal F, Orive G. Antibacterial effect of plasma rich in growth factors (PRGF(R)-Endoret(R)) against Staphylococcus aureus and Staphylococcus epidermidis strains. Clin Exp Dermatol. 2012;37(6):652–7. CrossRefPubMed
29.
Zurück zum Zitat Moojen DJ, Everts PA, Schure RM, Overdevest EP, van Zundert A, Knape JT, et al. Antimicrobial activity of platelet-leukocyte gel against Staphylococcus aureus. J Orthop Res. 2008;26(3):404–10. CrossRefPubMed Moojen DJ, Everts PA, Schure RM, Overdevest EP, van Zundert A, Knape JT, et al. Antimicrobial activity of platelet-leukocyte gel against Staphylococcus aureus. J Orthop Res. 2008;26(3):404–10. CrossRefPubMed
30.
Zurück zum Zitat Chen L, Wang C, Liu H, Liu G, Ran X. Antibacterial effect of autologous platelet-rich gel derived from subjects with diabetic dermal ulcers in vitro. J Diabetes Res. 2013;2013:269527. PubMedPubMedCentral Chen L, Wang C, Liu H, Liu G, Ran X. Antibacterial effect of autologous platelet-rich gel derived from subjects with diabetic dermal ulcers in vitro. J Diabetes Res. 2013;2013:269527. PubMedPubMedCentral
31.
Zurück zum Zitat Bielecki TM, Gazdzik TS, Arendt J, Szczepanski T, Krol W, Wielkoszynski T. Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: an in vitro study. J Bone Jt Surg Br. 2007;89(3):417–20. CrossRef Bielecki TM, Gazdzik TS, Arendt J, Szczepanski T, Krol W, Wielkoszynski T. Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: an in vitro study. J Bone Jt Surg Br. 2007;89(3):417–20. CrossRef
32.
Zurück zum Zitat Yang HS, Shin J, Bhang SH, Shin JY, Park J, Im GI, et al. Enhanced skin wound healing by a sustained release of growth factors contained in platelet-rich plasma. Exp Mol Med. 2011;43(11):622–9. CrossRefPubMedPubMedCentral Yang HS, Shin J, Bhang SH, Shin JY, Park J, Im GI, et al. Enhanced skin wound healing by a sustained release of growth factors contained in platelet-rich plasma. Exp Mol Med. 2011;43(11):622–9. CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Sun S, Wang C, Chen D, Cen S, Lv X, Wen X, et al. Combating superbug without antibiotic on a postamputation wound in a patient with diabetic foot. Int J Low Extrem Wounds. 2016;15(1):74–7. CrossRefPubMed Sun S, Wang C, Chen D, Cen S, Lv X, Wen X, et al. Combating superbug without antibiotic on a postamputation wound in a patient with diabetic foot. Int J Low Extrem Wounds. 2016;15(1):74–7. CrossRefPubMed
Metadaten
Titel
Platelet-rich plasma as an additional therapeutic option for infected wounds with multi-drug resistant bacteria: in vitro antibacterial activity study
verfasst von
Rıza Aytaç Çetinkaya
Ercan Yenilmez
Patrizio Petrone
Soner Yılmaz
Bayhan Bektöre
Berksan Şimsek
Tuğba Kula Atik
Mustafa Özyurt
Aytekin Ünlü
Publikationsdatum
26.04.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Trauma and Emergency Surgery / Ausgabe 3/2019
Print ISSN: 1863-9933
Elektronische ISSN: 1863-9941
DOI
https://doi.org/10.1007/s00068-018-0957-0

Weitere Artikel der Ausgabe 3/2019

European Journal of Trauma and Emergency Surgery 3/2019 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, DICOM-Daten, Videos und Abbildungen. » Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.